Search Results - "Sakemura, Noriko"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1
  2. 2

    Feasibility study on radiofrequency ablation followed by partial mastectomy for stage I breast cancer patients by Imoto, Shigeru, Wada, Noriaki, Sakemura, Noriko, Hasebe, Takahiro, Murata, Yukinori

    Published in Breast (Edinburgh) (01-04-2009)
    “…Abstract To evaluate the safety and reliability of thermal ablation therapy instead of breast-conserving surgery (BCS), we performed radiofrequency ablation…”
    Get full text
    Journal Article
  3. 3

    Invasive apocrine carcinoma of the breast: clinicopathologic features of 57 patients by Tanaka, Kimihiro, Imoto, Shigeru, Wada, Noriaki, Sakemura, Noriko, Hasebe, Kahiro

    Published in The breast journal (01-03-2008)
    “…Apocrine carcinoma is a rare, unique, and morphologically distinctive type of invasive ductal carcinoma (IDC). The features of invasive apocrine carcinoma…”
    Get more information
    Journal Article
  4. 4

    Hemochromatosis enhances tumor progression via upregulation of intracellular iron in head and neck cancer by Lenarduzzi, Michelle, Hui, Angela B Y, Yue, Shijun, Ito, Emma, Shi, Wei, Williams, Justin, Bruce, Jeff, Sakemura-Nakatsugawa, Noriko, Xu, Wei, Schimmer, Aaron, Liu, Fei-Fei

    Published in PloS one (26-08-2013)
    “…Despite improvements in treatment strategies for head and neck squamous cell carcinoma (HNSCC), outcomes have not significantly improved; highlighting the…”
    Get full text
    Journal Article
  5. 5

    Paradigm shift in axilla surgery for breast cancer patients treated with sentinel node biopsy by Imoto, Shigeru, Isaka, Hirotsugu, Sakemura, Noriko, Ito, Hiroki, Imi, Kentaro, Miyamoto, Kaisuke

    Published in Breast cancer (Tokyo, Japan) (01-04-2012)
    “…Background Sentinel node biopsy (SNB) is a standard technique for the diagnosis of regional lymph node metastases in clinically node-negative breast cancer…”
    Get full text
    Journal Article
  6. 6

    A porphodimethene chemical inhibitor of uroporphyrinogen decarboxylase by Yip, Kenneth W, Zhang, Zhan, Sakemura-Nakatsugawa, Noriko, Huang, Jui-Wen, Vu, Nhu Mai, Chiang, Yi-Kun, Lin, Chih-Lung, Kwan, Jennifer Y Y, Yue, Shijun, Jitkova, Yulia, To, Terence, Zahedi, Payam, Pai, Emil F, Schimmer, Aaron D, Lovell, Jonathan F, Sessler, Jonathan L, Liu, Fei-Fei

    Published in PloS one (25-02-2014)
    “…Uroporphyrinogen decarboxylase (UROD) catalyzes the conversion of uroporphyrinogen to coproporphyrinogen during heme biosynthesis. This enzyme was recently…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Abstract 5439: A novel drug sensitivity assay method for 3D cultured cell using an imaging device by Sakamoto, Ruriko, Sakemura, Noriko, Shimomura, Manami, Hirakawa, Noboru, Watanabe, Hirotada, Tanaka, Satoru, Yoshida, Kaori, Nakatsura, Tetsuya

    Published in Cancer research (Chicago, Ill.) (15-04-2011)
    “…Abstract Three-dimensional (3D) cultured cells are useful for the physiological study of tumor cells owing to their similar characteristics. Currently, the…”
    Get full text
    Journal Article
  10. 10

    Abstract 2688: Establishment of high avidity CTL clones induced by HLA-A2 restricted glypican-3 (GPC3) peptide vaccine by Yoshikawa, Toshiaki, Suzuki, Shiro, Nakatsugawa, Munehide, Shirakawa, Hirofumi, Nobuoka, Daisuke, Sakemura, Noriko, Motomura, Yutaka, Nakatsura, Tetsuya

    Published in Cancer research (Chicago, Ill.) (15-04-2011)
    “…Abstract Glypican-3 (GPC3) is an onco-fetal antigen which is overexpressed in human hepatocellular carcinoma (HCC) and that among normal tissues it is slightly…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Abstract 1555: Immune suppression of regulatory T cells and M2 macrophage in breast cancer patients by Imoto, Shigeru, Sakemura, Noriko, Ito, Hiroki, Imi, Kentaro, Isaka, Hirotsugu, Tazaki, Eri, Kanma, Hiroshi, Wada, Noriaki, Nakatsura, Tetsuya

    Published in Cancer research (Chicago, Ill.) (15-04-2011)
    “…Abstract Background: Recent multi-disciplinary treatments of breast cancer (BC) could decrease the mortality rate, but successful immune therapy remains…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Abstract 2510: A porphodimethene chemical inhibitor of uroporphyrinogen decarboxylase by Yip, Kenneth W., Zhang, Zhan, Sakemura-Nakatsugawa, Noriko, Huang, Jui-Wen, Yue, Shijun, Jitkova, Yulia, To, Terence, Pai, Emil, Schimmer, Aaron, Lovell, Jonathan, Sessler, Jonathan, Liu, Fei-Fei

    Published in Cancer research (Chicago, Ill.) (01-10-2014)
    “…Abstract Uroporphyrinogen decarboxylase (UROD), a heme biosynthetic pathway enzyme that converts uroporphyrinogen to coproporphyrinogen, was recently…”
    Get full text
    Journal Article